Fomivirsen for the treatment of cytomegalovirus retinitis

Editorial

Douglas A Jabs et al. Am J Ophthalmol. 2002 Apr.

. 2002 Apr;133(4):552-6.

doi: 10.1016/s0002-9394(02)01325-9.

No abstract available

Comment on

A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with AIDS.
Vitravene Study Group. Vitravene Study Group. Am J Ophthalmol. 2002 Apr;133(4):467-74. doi: 10.1016/s0002-9394(02)01327-2. Am J Ophthalmol. 2002. PMID: 11931780 Clinical Trial.
Randomized dose-comparison studies of intravitreous fomivirsen for treatment of cytomegalovirus retinitis that has reactivated or is persistently active despite other therapies in patients with AIDS.
Vitravene Study Group. Vitravene Study Group. Am J Ophthalmol. 2002 Apr;133(4):475-83. doi: 10.1016/s0002-9394(02)01326-0. Am J Ophthalmol. 2002. PMID: 11931781 Clinical Trial.
Safety of intravitreous fomivirsen for treatment of cytomegalovirus retinitis in patients with AIDS.
Vitravene Study Group.. Vitravene Study Group.. Am J Ophthalmol. 2002 Apr;133(4):484-98. doi: 10.1016/s0002-9394(02)01332-6. Am J Ophthalmol. 2002. PMID: 11931782 Clinical Trial.